Medigen Selected for WHO Trial

Published

By Asnaya Chou/Sandy Chi

Taiwan’s homegrown COVID vaccine, Medigen, is set to enter clinical trials under a WHO platform. The government hopes this could pave the way for greater international approval of the vaccine.